id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2025-0885-0003,DEA,DEA-2025-0885,HHS letter to DEA Bromazolam 07102025,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:51Z,,0,0,09000064b90d40f8
DEA-2025-0885-0002,DEA,DEA-2025-0885,HHS letter to DEA Bromazolam 06282024,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:46Z,,0,0,09000064b90d40f6
DEA-2025-0885-0001,DEA,DEA-2025-0885,Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I,Proposed Rule,,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,,2025-12-15T20:45:21Z,2025-22763,0,0,09000064b90d3470
DEA-2025-0885-0004,DEA,DEA-2025-0885,DEA 3-Factor Analysis Bromazolam December 2025,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:54Z,,0,0,09000064b90d40f7